Presentation is loading. Please wait.

Presentation is loading. Please wait.

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence  Mariya Rozenblit, BA, Mayte Suarez-Farinas,

Similar presentations


Presentation on theme: "Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence  Mariya Rozenblit, BA, Mayte Suarez-Farinas,"— Presentation transcript:

1 Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence  Mariya Rozenblit, BA, Mayte Suarez-Farinas, PhD, Avner Shemer, MD, Saakshi Khattri, MD, Patricia Gilleaudeau, NP, Mary Sullivan- Whalen, NP, Xiuzhong Zheng, MSc, Hui Xu, MSc, Irma Cardinale, MSc, James G. Krueger, MD, PhD, Emma Guttman-Yassky, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 134, Issue 4, Pages (October 2014) DOI: /j.jaci Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Histologic changes corresponding with CsA RDGP. A, Representative images of AD lesions after CsA treatment. Representative staining in nonlesional (NL) and lesional (LS) skin before and after 2 and 12 weeks of CsA treatment, with black arrows indicating increased staining of CLDN8 (B) and LEP (C) and white arrows indicating faint/discontinuous staining of CLDN23 (D). E, Increase in langerin+ cells after CsA treatment. Scale bars = 100 μm. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig E1 Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence  Mariya Rozenblit, BA, Mayte Suarez-Farinas,"

Similar presentations


Ads by Google